Categories: Government agency news release

11/28/2016

FDA release on Intrarosa approval omits important conflict of interest

10/18/2016

Steroid treatment for preterm infants: NIH release skimps on data and study limitations

9/30/2016

FDA release offers inadequate presentation of auto-inflammatory drug approval

7/6/2016

FDA release on hepatitis C drug informs on harms, benefits but is light on evidence

5/26/2016

Once again, NIH release on blood pressure targets lacks info on absolute benefits, potential harms

1 5/24/2016

FDA PR release on bladder cancer drug skirts lack of long-term survival data

1 5/10/2016

FDA release on drug for treating Parkinson’s psychosis lacks some key details

4/14/2016

NIH release delivers most of the goods on long-term heart surgery outcomes

3/29/2016

Release on federally funded anti-smoking campaign describes impressive reach but unclear on cost

3/2/2016

Exemplary explanation of study comparing diabetic macular edema treatments

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsReview.org @healthnewsrevu ·

The tale of two “negative” studies. Or, how spin is applied to make research findings look more impressive. A must read. https://johnmandrola.substack.com/p/the-tale-of-two-negative-studies

Reply on Twitter 1541491162799800323 Retweet on Twitter 1541491162799800323 1 Like on Twitter 1541491162799800323 2 Twitter 1541491162799800323

Retweet on Twitter HealthNewsReview.org Retweeted

Carolyn Thomas ☮️ @heartsisters ·

The @nytimes chose to interview one of the editors of the @AnnalsofIM (publisher of this paper) who "gushed with extraordinary glee: It’s huge! There are very few things that reduce your mortality by 30%."
Turns out coffee is not one of those few things despite all that glee. https://twitter.com/garyschwitzer/status/1533202075928215558

Reply on Twitter 1539728971138338816 Retweet on Twitter 1539728971138338816 1 Like on Twitter 1539728971138338816 5 Twitter 1539728971138338816